Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — H1 2017 Earnings Presentation
19 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Jul 27, 2017
Slide 1: Conference call Interim report January 1 to June 30, 2017
Worldwide. On Site. Conference call Interim report January 1 to June 30, 2017 Lübeck, July 27, 2017
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Business Highlights H1
Business Highlights H1 Net Sales Order intake continued to improve in Q2. Orders on hand significantly +1.0% 0.0% above prior year’s level. Currency Currency adjusted 1,116 Order intake (currency adjusted): adjusted Q2 +7.0% yoy 581 H1 +6.2% yoy 1,111 579 Net sales development still lagging be
Slide 4: Order development in H1
Order development in H1 Order entry (€ million) Group Medical Safety Net Sales America 259 +6.6% +10.5% -1.4% +2.8% Africa, Asia, +4.4% +13.0% -2.0% 336 +6.6% Australia Europe 707 +5.9% +1.9% +11.9% -0.2% Group 1,302 +6.2% +4.4% +9.7% 0.0% Growth rates are net of currency effects 4
Slide 5: Business development H1 Group
Business development H1 Group Q2 2016 Q2 2017 Change 6M 2016 6M 2017 Change € million € million % € million € million % Order Intake 621.4 662.7 6.6 1,221.1 1,302.0 6.6 % growth (FX adjusted) 0.9% 7.0% 0.5% 6.2% Net Sales 579.0 581.0 0.3 1,111.4 1,116.0 0.4 % growth (FX adjusted) -6.3% 1.0% -3.3% 0.
Slide 6: Functional Expenses
Functional Expenses 6M 2016 6M 2017 Change Change net of FX and restructuring € million € million % % R&D -109.9 -111.9 1.7 1.7 % of Net Sales -9.9% -10.0% Sales & Marketing -268.5 -272.0 1.3 0.7 % of Net Sales -24.2% -24.4% Administration -101.9 -91.1 -10.5 -5.1 % of Net Sales -9.2% -8.2% SG&A -370
Slide 7: Key Figures
Key Figures 6M 2016 6M 2017 Change € million € million % Cashflow from operating activities 42.4 31.2 -26.3 Investments 49.3 42.1 -14.6 Cash and cash equivalents1 162.2 175.7 8.3 Net financial debt1 150.6 41.8 -72.3 Net financial debt 1 /EBITDA 2 1.12 0.18 1 Capital employed 1,259.2 1,229.9 -2.3 2 1
Slide 8: Business development H1 Segments
Business development H1 Segments EBIT- Order entry Net sales Net sales EBIT margin Δ in %* € million Δ in %* € million % Europe 5,9 618,3 -0,2 19,3 3,1 America 6,6 227,7 2,8 -3,9 -1,7 Africa, Asia, Australia 6,6 270,0 -2,0 3,7 1,4 Group 6,2 1116,0 0,0 19,1 1,7 Medical 4,4 706,4 -0,2 -4,4 -0,6 Safety
Slide 9: Outlook
Outlook 2016 2017e Net Sales - 1.5 % 0.0 % – 3.0 % (net of currency effects) EBIT margin 5.4 % 5.0 % – 7.0 %* Gross profit margin 45.0 % 44.0 – 46.0 % Dräger Value Added EUR 49.8m EUR 40m – 90m * based on exchange rates at the start of the year 2017 9
Slide 10: Questions & Answers
Questions & Answers Drager a: we 10 Drager. Technik fiir das Leben*
Slide 11: Appendix
Appendix Urager 1 ea |
Slide 12: Business development Segments Q2
Business development Segments Europa Amerika Afrika, Asien, Australien Dräger Konzern Q2 2016 Q2 2017 Q2 2016 Q2 2017 Q2 2016 Q2 2017 Q2 2016 Q2 2017 € million € million € million € million € million € million € million € million Order entry 349.2 359.2 120.8 134.4 151.4 169.1 621.4 662.7 Net Sales
Slide 13: Business development Segments H1
Business development Segments Europa Amerika Afrika, Asien, Australien Dräger Konzern 6M 2016 6M 2017 6M 2016 6M 2017 6M 2016 6M 2017 6M 2016 6M 2017 € million € million € million € million € million € million € million € million Order entry 673.2 706.8 236.6 259.1 311.3 336.2 1,221.1 1,302.0 Net Sa
Slide 14: Business development Medical
Business development Medical Q2 2016 Q2 2017 Change Change 6M 2016 6M 2017 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 417.3 435.7 4.4 4.5 800.7 841.0 5.0 4.4 Europe 221.6 216.8 -2.1 -2.0 408.3 414.7 1.6 1.9 America 83.2 97.7 17.4 16.5 159.9 181.4 13
Slide 15: Business development Safety
Business development Safety Q2 2016 Q2 2017 Change Change 6M 2016 6M 2017 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 204.2 226.9 11.2 12.1 420.4 461.1 9.7 9.7 Europe 127.6 142.4 11.6 13.4 264.8 292.0 10.3 11.9 America 37.7 36.7 -2.5 -2.6 76.6 77.7 1
Slide 16: Cash-flow statement
Cash-flow statement 6M 2016 6M 2017 Change € million € million % Group net profit -1.1 8.2 >100 Change in inventories -38.1 -59.0 -54.7 Change in receivables 122.7 133.8 9.1 Change in payables -31.1 -23.7 23.9 Depreciation and amortization 40.9 41.0 0.2 Other operating cash flow items -50.9 -69.2 -3
Slide 17: Earnings per share
Earnings per share 2012 2013 2014 2015 2016 Net profit in € thousand 135,680 119,895 104,666 33,288 81,736 Earnings attributable to non-controlling interests in € thousand 3,319 563 105 287 345 Szenario: 100% distribution: pay-out ratio 100% 100% 100% 100% 100% Earnings attributable to participation
Slide 18: Financial calendar 2017
Financial calendar 2017 March 8, 2017 - Accounts press conference, Lübeck - Analysts meeting May 4, 2017 - Report for the first three months 2017 Conference call, Lübeck May 10, 2017 - Annual shareholders' meeting, Lübeck July 27, 2017 - Report for the first six months 2017 Conference call, Lübeck N
Slide 19: Contact
Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88
Drägerwerk AG & Co. KGaA — H1 2017 Earnings Presentation on 6ix